Taxane combined with lobaplatin or anthracycline for neoadjuvant chemotherapy of triple-negative breast cancer: a randomized, controlled, phase II study

Taxane combined with lobaplatin or anthracycline for neoadjuvant chemotherapy of triple-negative breast cancer: a randomized, controlled, phase II study

Abstract Background Previous studies have shown that the addition of platinum to neoadjuvant chemotherapy (NAC) improved outcomes for patients with triple-negative breast cancer (TNBC). However, no studies have assessed the efficacy and safety of the combination of taxane and lobaplatin. In this stu...

Full description

Bibliographic Details
Main Authors: Cheng Wang, Long Yuan, Xiujuan Wu, Yan Wang, Hao Tian, Guozhi Zhang, Andi Wan, Siyi Xiong, Chengfang Wang, Yuqin Zhou, Dandan Ma, Yangqiu Bao, Man Qu, Jun Jiang, Yi Zhang, Xiaowei Qi
Format: Article
Language:English
Published: BMC 2024-06-01
Series:BMC Medicine
Subjects:
Neoadjuvant chemotherapy
TNBC
taxane
Lobaplatin
Anthracycline
pCR
Online Access:https://doi.org/10.1186/s12916-024-03474-0

Internet

https://doi.org/10.1186/s12916-024-03474-0

Similar Items